focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.80
Bid: 7.50
Ask: 7.98
Change: -0.04 (-0.51%)
Spread: 0.48 (6.40%)
Open: 8.40
High: 8.40
Low: 7.70
Prev. Close: 7.84
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Dec 2016 09:41

RNS Number : 3220R
Oxford BioDynamics PLC
08 December 2016
 
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

OXFORD BIODYNAMICS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

PHILIPPA MARGARET HOYER MILLAR

 

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

06 DEC 2016

6. Date on which issuer notified:

07 DEC 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BD5H8572

5,360,400

5,360,400

4,473,140

4,473,140

5.2%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,473,140

5.2%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

Philippa Hoyer Millar

 

15. Contact telephone number:

01865516405

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEANAPEDXKFEF
Date   Source Headline
5th May 20227:00 amRNSOBD to present CiRT clinical utility data at ASCO
28th Apr 202210:54 amRNSDirector/PDMR Shareholding
11th Apr 202212:00 pmRNSHolding(s) in Company
8th Apr 202210:40 amRNSPDMR Dealing
7th Apr 202210:36 amRNSPDMR Dealing
6th Apr 20224:14 pmRNSPDMR Dealing
6th Apr 20224:03 pmRNSPDMR Dealing
30th Mar 20222:09 pmRNSResults of Annual General Meeting
4th Mar 20229:42 amRNSPDMR Dealing
3rd Mar 20229:58 amRNSPDMR Dealing
1st Mar 20224:16 pmRNSPUBLICATION OF 2021 ANNUAL REPORT
25th Feb 20227:00 amRNSUS launch of EpiSwitch® CiRT for oncology
15th Feb 202210:17 amRNSPDMR Dealing
10th Feb 202211:52 amRNSPDMR Dealing
8th Feb 20223:10 pmRNSHolding(s) in Company
7th Feb 20222:47 pmRNSPDMR Dealing
26th Jan 20229:50 amRNSPDMR Dealing
25th Jan 202211:44 amRNSPDMR Dealing
25th Jan 20227:00 amRNSFinal Results
19th Jan 20229:58 amRNSHolding(s) in Company
14th Jan 20222:36 pmRNSHolding(s) in Company
14th Jan 20227:00 amRNSHolding(s) in Company
13th Jan 202212:00 pmRNSHolding(s) in Company
11th Jan 20229:00 amRNSHolding(s) in Company
10th Jan 20227:02 amRNSHolding(s) in Company
4th Jan 20227:00 amRNSHolding(s) in Company
29th Dec 20214:00 pmRNSHolding(s) in Company
24th Dec 202111:40 amRNSPDMR Dealing
23rd Dec 20217:00 amRNSNotice of Results
17th Dec 20217:00 amRNSOBD updates on EpiSwitch CST and CiRT tests
13th Dec 20212:23 pmRNSHolding(s) in Company
13th Dec 202110:12 amRNSPDMR Dealing
1st Dec 202112:00 pmRNSPDMR Dealing
24th Nov 20213:02 pmRNSPDMR Dealing
22nd Nov 202111:00 amRNSPDMR Dealing
18th Nov 20213:16 pmRNSHolding(s) in Company
18th Nov 20213:10 pmRNSPDMR Dealing
18th Nov 202111:53 amRNSHolding(s) in Company
11th Nov 202111:08 amRNSResults of General Meeting
4th Nov 20217:00 amRNSHolding(s) in Company
2nd Nov 202112:22 pmRNSHolding(s) in Company
1st Nov 202112:43 pmRNSTotal Voting Rights
1st Nov 20217:00 amRNSHolding(s) in Company
25th Oct 20212:45 pmRNSOBD raises £3.62 million
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSChange of Registered Office
31st Aug 20217:00 amRNSOxford BioDynamics awarded US FNIH Grant
15th Jun 20211:06 pmRNSPDMR Dealing
15th Jun 20217:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.